Comparison of Clinical Response to D-Mannose with Behavioral Modifications Versus Behavioral Modifications Alone in Asymptomatic Pyuria During Pregnancy
Comparison of D-Mannose with Behavioral Modifications
DOI:
https://doi.org/10.54393/pjhs.v5i07.1566Keywords:
Asymptomatic Pyuria, D-Mannose, Behavioral Modifications, Pregnancy, Resolution of Asymptomatic PyuriaAbstract
The physiological and structural changes during pregnancy cause ureteral dilatation and urine stasis, which can lead to asymptomatic and symptomatic infections. Objective: To compare the clinical response between d-mannose with behavioral modifications versus behavioral modifications alone in asymptomatic pyuria during pregnancy. Methods: A quasi experimental study was conducted from April to September 2021, in the Department of Gynecology and Obstetrics Maternal and Child Health Center unit-1, PIMS, Islamabad. A total of 130 women with diagnoses of asymptomatic pyuria matching the inclusion criteria were recruited during study period and assigned to two groups by consecutive non-probability sampling method. Patients with urinary tract abnormalities, GDM, and antibiotic-treated symptomatic UTIs were excluded. Group A was instructed to take 1 g of D-mannose twice daily and follow the advises about behavioral changes.The group B was instrcucted to follow behavioral change only. pus cells in urine R.E.reports were used to evaluate response of treatments. Results: According to the study, the mean age of patients in group A was 27.69 ± 4.04 years, whereas group B had a mean age of 28.85 ± 4.12 years. The majority of patients (61.54%) were aged 15-30. Patients in group A had a mean gestational age of 23.72 ± 3.19 weeks, whereas group B had 24.26 ± 3.23 weeks. Patients had a mean BMI of 29.65 ± 3.55 kg/m2. In group A; 23 (35.18%) and in group B 11 (16.92%) cases of asymptomatic pyuria achieved reolution.Conclusions: This study found that D-mannose with behavioral adjustments resolves asymptomatic pyuria during pregnancy better than behavioral modifications alone.
References
Emami A, Javanmardi F, Pirbonyeh N. Antibiotic resistant profile of asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy. 2020 Aug; 18(8): 807-15. doi:10.1080/14787210.2020.1759420. DOI: https://doi.org/10.1080/14787210.2020.1759420
Abdel-Gawad M. Ureteral Disorders During Pregnancy. InThe Ureter: A Comprehensive Review. Cham: Springer International Publishing. 2024; 591-612. doi:10.1007/978-3-031-36212-5_24. DOI: https://doi.org/10.1007/978-3-031-36212-5_24
Ghouri F, Hollywood A. Antibiotic prescribing in primary care for urinary tract infections (UTIs) in pregnancy: an audit study. Medical Sciences. 2020 Sep; 8(3): 40. doi:10.3390/medsci8030040. DOI: https://doi.org/10.3390/medsci8030040
Hernández-Hernández D, Padilla-Fernández B, Ortega-González MY, Castro-Díaz DM. Recurrent urinary tract infections and asymptomatic bacteriuria in adults. Current Bladder Dysfunction Reports. 2021 Dec: 1-2. doi:10.1007/s11884-021-00638-z. DOI: https://doi.org/10.1007/s11884-021-00638-z
Asha Rani S, Anitha TK, Trupti VR, Maumita Deb AA, Nawaz Umar M, Poornima K. Prevalence And Bacteriological Profile Of Symtomatic And Asymptomatic Bacteriuria During Pregnancy. Journal of Pharmaceutical Negative Results. 2022 Dec: 4148-54.
Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1988 Mar 1; 27(3): 249-59. doi: DOI: https://doi.org/10.1016/0028-2243(88)90130-X
Khursheed F, Madhudas C, Saima Ghaffar B. Asymptomatic bacteriuria (ASB) in pregnancy: prevalence and fetal risk. Pakistan Journal of Medical & Health Sciences. 2022 Apr;16(03): 426-. doi:10.53350/pjmhs22163426. DOI: https://doi.org/10.53350/pjmhs22163426
Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N, Wolfe AJ. Urinary bacteria in adult women with urgency urinary incontinence. International urogynecology journal. 2014 Sep;25:1179-84. DOI: https://doi.org/10.1007/s00192-013-2325-2
Parazzini F, Ricci E, Fedele F, Chiaffarino F, Esposito G, Cipriani S. Systematic review of the effect of D mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis. Biomedical Reports. 2022 Aug; 17(2): 1-1. doi: 10.3892/br.2022.1552. DOI: https://doi.org/10.3892/br.2022.1552
Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L. Role of D-mannose in urinary tract infections–a narrative review. Nutrition Journal. 2022 Mar; 21(1): 18. doi: 10.1186/s12937-022-00769-x. DOI: https://doi.org/10.1186/s12937-022-00769-x
Faustino M, Silva S, Costa EM, Pereira AM, Pereira JO, Oliveira AS, Ferreira CM, Pereira CF, Durão J, Pintado ME, Carvalho AP. Effect of mannan oligosaccharides extracts in uropathogenic escherichia coli adhesion in human bladder cells. Pathogens. 2023 Jun; 12(7): 885. doi: 10.3390/pathogens12070885. DOI: https://doi.org/10.3390/pathogens12070885
Hayward G, Mort S, Hay AD, Moore M, Thomas NP, Cook J, Robinson J, Williams N, Maeder N, Edeson R, Franssen M. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Internal Medicine. 2024 Jun; 184(6): 619-28. doi: 10.1001/jamainternmed.2024.0264. DOI: https://doi.org/10.1001/jamainternmed.2024.0264
Chen YC, Lee WC, Chuang YC. Emerging non-antibiotic options targeting uropathogenic mechanisms for recurrent uncomplicated urinary tract infection. International Journal Of Molecular Sciences. 2023 Apr; 24(8): 7055. doi:10.3390/ijms24087055. DOI: https://doi.org/10.3390/ijms24087055
Alton G, Kjaergaard S, Etchison JR, Skovby F, Freeze HH. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochemical and molecular medicine. 1997 Apr 1;60(2):127-33. DOI: https://doi.org/10.1006/bmme.1997.2574
Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal Of Obstetrics And Gynecology. 2020 Aug; 223(2): 265-e1. doi: 10.1016/j.ajog.2020.05.048. DOI: https://doi.org/10.1016/j.ajog.2020.05.048
Kyriakides R, Jones P, Somani BK. Role of D-mannose in the prevention of recurrent urinary tract infections: evidence from a systematic review of the literature. European Urology Focus. 2021 Sep; 7(5): 1166-9. doi:10.1016/j.euf.2020.09.004. DOI: https://doi.org/10.1016/j.euf.2020.09.004
Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnick LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International journal of antimicrobial agents. 2005 Nov 1;26(5):380-8. DOI: https://doi.org/10.1016/j.ijantimicag.2005.08.003
Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious Disease Clinics. 2003 Jun 1;17(2):227-41. DOI: https://doi.org/10.1016/S0891-5520(03)00005-9
Albert X, Huertas I, Pereiro I, Sanfélix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non‐pregnant women. Cochrane Database of Systematic Reviews. 2004(3). DOI: https://doi.org/10.1002/14651858.CD001209.pub2
Genovese C, Davinelli S, Mangano K, Tempera G, Nicolosi D, Corsello S, Vergalito F, Tartaglia E, Scapagnini G, Di Marco R. Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. Journal of Chemotherapy. 2018 Feb; 30(2): 107-14. doi:10.1080/1120009X.2017.1393587. DOI: https://doi.org/10.1080/1120009X.2017.1393587
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
